
Genmab
Differentiated human antibody therapeutics for the treatment of cancer.
Enterprise value
$9.6b
Share price
DKK2491.00 GMAB
Company register number
21023884
Recent deals
Authorizing premium user...
Differentiated human antibody therapeutics for the treatment of cancer.